(Q67242843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Biochemical and pharmacologic studies with 1-β-d-arabinofuranosylcytosine 5′-adamantoate (NSC-117614), a depot form of cytarabine (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

author name string

G. L. Neil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

H. H. Buskirk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

T. E. Moxley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

R. C. Manak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

S. L. Kuentzel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

B. K. Bhuyan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002403

27 March 2023

language of work or name

English

0 references

publication date

1 December 1971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 September 2019

https://api.elsevier.com/content/article/PII:0006295271904345?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

https://api.elsevier.com/content/article/PII:0006295271904345?httpAccept=text/plain

27 March 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

3295-3308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

2

30

1047

Neil

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

Immunosuppressive effects of adamantoyl cytarabine. I. Inhibition of hemagglutinin formation and graft versus host reactions in mice.

27 March 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

7

19

843

Smith

1959

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

9

29

1036

Bach

1969

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

11

30

2760

Li

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

27 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

Studies of the enzymatic deamination of ara-cytidine. V. inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides

27 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

19

30

2166

Neil

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

The adamantyl group in medicinal agents. 3. Nucleoside 5'-adamantoates. The adamantoyl function as a protecting group.

27 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells

27 March 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

24

28

2061

Furth

1968

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

26

28

793

Schrecker

1968

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

27

25

1446

Silagi

1965

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity

27 March 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside

27 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-2952(71)90434-5

27 March 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002403%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference